Abstract
Echinococcus granulosus is a causative agent of cystic echinococcosis disease which represents a real challenge of health and economic sectors by threatening human and animal life. In E. granulosus-infected intermediate hosts, the local immune responses represent by balance between T helper-1 (Th1)/Th2 responses and involving of IL-10-secreting CD8+ T cells, as well as induction of antigen presentation and production of antibodies were suggested. Spill out of hydatid cyst fluid from ruptured cysts can induce deadly anaphylactic reactions. Although the host promotes effective immune responses against E. granulosus infection, the parasite can be survived, suggesting exist of mechanisms of immune evasion that help E. granulosus to grow and develop. Several mechanisms of immune evasion have been suggested during E. granulosus infection including; antigenic variation that lead to produce useless antibodies, alteration of Th1/Th2 cytokine profile, anti-apoptotic process, molecular mimicry and interfering with Antigen presentation, as well as fibrosis of hydatid cysts can be occurred in chronic cases. Furthermore, as an efficient drug against E. granulosus infection still not available, immunization of hosts could be necessary. Interestingly, combination of multiple EG95 proteins of oncospheres from the different isomers could possibly maximize the EG95 vaccine efficacy.
Keywords
- E. granulosus
- hydatid cysts
- anaphylactic reactions
- immune evasion
1. Introduction
Cystic echinococcosis is a neglected zoonotic disease as recognized by world Health organization. The disease is caused by a parasite tapeworm of the
The early stage of
2. Host immune responses in E. granulosus infection
2.1 Innate immune responses
The innate immunity is a part of immune system responsible for generating the early immune responses against non-specific pathogens. Host–parasite interaction complex is the baseline of immune response regulation, where cross-stimulation that mediated by a package of immune cells, receptors and sensors can work together to induce effective immune response against pathogen [3]. The level of Toll-like receptor2 (TLR2) and 4 (TLR4) can increase in the early stage of cystic echinococcosis suggesting a trigger role of them in innate immune responses by activation of myeloid differentiation factor 88 (MyD88) and important transcription factors, such as nuclear factor-κB (NF-κB), interferon regulatory factors) IRFs) and mitogen-activated protein kinase (MAPKs(leading to promote secretion of pro-inflammatory cytokines [4].
Furthermore, during establishment stage of hydatid cysts, induction of the innate immune responses are generated by an increase in the number of monocytes and macrophages with infiltration of neutrophils and macrophages into the site of damaged tissues. Involvement of the innate susceptibility/resistance (s/r) factors in host–parasite interaction include; activation of complement, nonspecific phagocytosis and cytolytic leukocytes. Moreover, feature of leukocytosis as a result of increase in the number of circulating neutrophils, eosinophils, lymphocytes, and macrophages are common indicators during
2.2 Adaptive immune responses
Adaptive immune response is another type of immune responses generated against specific pathogen. There are two types of adaptive immunity including; cellular and humoral immunity. Understanding the local liver immune responses may contribute in designing new therapies and blocking immune evasion mechanisms during establishment stage of parasite infection. The second challenge of host by oncospheral antigen after 21 days from primary infection provided high level of protection. This likely due to the role of antibody-dependent cell-mediated cytotoxicity (ADCC) reactions [7]. In CD4 T cells- deficient mice that immunized with protoscoleces (E4+) antigen, production of CD4+ T cell-independent antibodies was determined in the early stage of infection [8]. The term of humoral immunity refers to antibody-mediated immune response that occurs when antigen presenting cells such as macrophages and DCs engulf antigens and expose them on their surfaces to amplify immune responses against specific pathogen [9]. In early stage of experimental infection of
3. Mechanisms of immune evasion of E. granulosus
The real challenge for any pathogen is been survival as unwanted visitor in inconvenient environment. Therefore, to avoid effective immune responses of the host,
3.1 Protective role of hydatid cyst wall
In intermediate hosts, the first protective barrier following hydatid cyst (metacestode) formation is cyst wall. The hydatid cyst wall consist of outer membrane called laminated layer (antigenic variant layer) and inner layer called germinal layer responsible for production of protoscoleces. Although the hydatid cyst wall consist of different proteins which they can motivate immune responses against parasite, but it also provides physical protection from immune components [12]. Additionally, some of the host molecules that involve in immune response and protective action can be sequestrated in hydatid cyst fluid suggesting that the host molecules may absorbed by laminated germinal layers during host–parasite interaction [13].
3.2 Control of host complement system
Complement is a part of immune system represented by a serial of soluble proteins, membrane expressed receptors and regulators, where blocking of complement can cause perturbation in defense system of host against pathogens [14]. In the early stage of infection, deactivation of host complement can be occurred during several diseases including cystic echinococcosis. This complement deactivation lead to inhibition of acute inflammatory responses which include; boost of vascular permeability, infiltration of leukocytes, and chemotaxis of immune cells into infection site [15].
In alternative way of complement activation, triggering of complement cascade occurred by cleavage C3 into C3b and iC3b which is essential for producing membrane attack complex (MAC) of complement. The complement activation is regulated by host inhibitor factor H (FH), where FH binds with C3b component of complement leading to complement inhibition to protect host cells from self-attack by complement [16]. Preventing accumulation of complement cascade on the pathogen surface and perturbation in phagocytosis has been described by interaction between complement inhibitor FH and FH-binding proteins of many pathogens including
3.3 Interference with infiltration of immune cells
Migration of immune cells from circulatory system into the various organs and tissues during normal and inflammatory conditions are common events in host body. In experimental cystic echinococcosis following by ingestion of mice with ovalbumin (OVA) after 3 months post infection to induce asthma model, the histopathological data indicated the ability of
3.4 Manipulation of dendritic cells
Dendritic cells (DCs) are the most efficient antigen presenting cells that uptake the pathogen antigens and exposed them to the Th2 cells to trigger production of antibodies by B lymphocyte cells. It has been found that hydatid cyst fluid can directly modulate predifferentiated DCs and impairing their ability to release interleukin 12 (IL-12), IL-6 and prostaglandin E2 (PGE2) [20]. The effect of purified AgB and sheep hydatid fluid (SHF) of
3.5 Molecular mimicry
Molecular mimicry refers to the similarity in sequencing between specific pathogen antigens with some host’s self-antigens, where many pathogens have ability to share molecules has sequencing similar to the host antigens. According to the molecular mimicry strategy, the pathogen antigens can be recognized as a “Self” antigen, which helps to protect parasite from host immune responses [25]. The metacestodes of
3.6 Interference with secretion of cytokines and chemokines
The interaction between
In another study, interfering with immune response against protoscoleces in the early stage of infection has been suggested as a mechanism of evasion, where co-culture of protoscoleces with peripheral blood mononuclear cells
Although, the glycan antigens of
Further
3.7 Anti-apoptosis strategy
Apoptosis, a first type of programmed cell death is controlled by a serial of proteins and enzymes responsible for cascade of events in unicellular and multicellular organisms during infection and normal conditions. Apoptosis is a route of cell transformation during normal growth, as well as it serves as a protective mechanism by eliminating of damaged cells, infectious agents and malignant cells. There are two ways to promote apoptosis including; extrinsic and intrinsic routes. The protoscoleces of
Furthermore, it has been shown that some of hydatid cysts can be free of protoscoleces called infertile hydatid cysts and this may be attributed to high expression of apoptotic components. In related to that, high level of DNA fragmentation and caspase-3 were detected in infertile hydrated cysts as compared to fertile cysts suggesting that apoptosis can be involved in hydatid cyst infertility [36]. The study obtained by Amirmajdi
3.8 Camouflage strategy
According to the previous literatures, using camouflage strategy by invading pathogens allow them to stay survival in their hosts, where pathogens can exploit host components and secretions such as cells, proteins and enzymes to avoid effect of immune responses against them. The outermost layer around hydatid cysts of
3.9 Antigenic variation
Antigenic variation or antigenic alteration is the ability of pathogens such as parasites, bacteria and viruses to alter the exposed proteins and carbohydrates on their body surfaces regularly to avoid been recognized by host immune cells. This strategy can help pathogen to dispose the generated effective immune response [41]. It has been shown the ability of
3.10 Interfering with antigen presentation capability
Antigen presentation refers to expose components of pathogen on the surface of antigen presenting cells including; macrophages, DCs and B cells through the major histocompatibility complex type two (MHC-II) receptors to the specific immune cells. Antigen presentation is a major process of adaptive immune response that includes; recognition, phagocytosis and exposure of pathogen antigens by antigen presenting cells following by recognition of antigens through Th lymphocyte cells [43].
4. Vaccination against E. granulosus parasites
At the early stage of
Another candidate vaccine that has been used to immunize intermediate hosts is protoscolex tegumental surface antigens (PSTSA). The data from PSTSA-immunized sheep showed an increase in the titer of antibodies after single and double immunization [51]. Furthermore, three recombinant proteins of egM gene family of
More recently, it has been shown that multi-epitope combination vaccine of
5. Conclusions
Overall, the outcome data from previous literatures about
Acknowledgments
I would like to thank the Ministry of higher Education and Scientific Research of Iraq, University of Mosul, College of Education for Pure Science, Department of Biology for their unlimited support and encourage their academic staff to participate in international Publishing and collaboration with international organizations.
References
- 1.
Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, et al. Echinococcosis: Advances in the 21st century. Clinical Microbiology Reviews. 2019; 32 (2):e00075-e00018 - 2.
Anvari D, Rezaei F, Ashouri A, Rezaei S, Majidiani H, Pagheh AS, et al. Current situation and future prospects of Echinococcus granulosus vaccine candidates: A systematic review. Transboundary and Emerging Diseases. 2021;68 (3):1080-1096 - 3.
Vanalli C, Mari L, Righetto L, Casagrandi R, Gatto M, Cattadori IM. Within-host mechanisms of immune regulation explain the contrasting dynamics of two helminth species in both single and dual infections. PLoS Computational Biology. 2020; 16 (11):e1008438 - 4.
Tuxun T, Ma HZ, Apaer S, Zhang H, Aierken A, Li YP, et al. Expression of toll-like receptors 2 and 4 and related cytokines in patients with hepatic cystic and alveolar echinococcosis. Mediators of Inflammation. 2015; 2015 :632760 - 5.
Zhang W, Li J, McManus DP. Concepts in immunology and diagnosis of hydatid disease. Clinical Microbiology Reviews. 2003; 16 (1):18-36 - 6.
Hirayama D, Iida T, Nakase H. The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis. International journal of molecular sciences. 2017; 19 (1):92 - 7.
Zhang W, You H, Zhang Z, Turson G, Hasyet A, McManus DP. Further studies on an intermediate host murine model showing that a primary Echinococcus granulosus infection is protective against subsequent oncospheral challenge. Parasitology International. 2001; 50 (4):279-283 - 8.
Baz A, Carol H, Fernández V, Mourglia-Ettlin G, Nieto A, Örn A, et al. Echinococcus granulosus : Induction of T-independent antibody response against protoscolex glycoconjugates in early experimental infection. Experimental Parasitology. 2008;119 (4):460-466 - 9.
Snapper CM. Cytokine Regulation of Humoral Immunity: Basic and Clinical Aspects. USA: John Wiley & Sons Ltd; 1996 - 10.
Mourglia-Ettlin G, Marques JM, Chabalgoity JA, Dematteis S. Early peritoneal immune response during Echinococcus granulosus establishment displays a biphasic behavior. PLoS Neglected Tropical Diseases. 2011;5 (8):e1293 - 11.
Pawłowski ZS, Eckert J, Vuitton DA, Ammann RW, Kern P, Craig PS, et al. Echinococcosis in humans: Clinical aspects, diagnosis and treatment. In: WHO/OIE Manual on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern. World Organization for Animal Health. France: Office International des Épizooties; 2001:20-66 - 12.
Siracusano A, Riganò R, Ortona E, Profumo E, Margutti P, Buttari B, et al. Immunomodulatory mechanisms during Echinococcus granulosus infection. Experimental Parasitology. 2008;119 (4):483-489 - 13.
Dos Santos GB, Monteiro KM, da Silva ED, Battistella ME, Ferreira HB, Zaha A. Excretory/secretory products in the Echinococcus granulosus metacestode: Is the intermediate host complacent with infection caused by the larval form of the parasite? International Journal for Parasitology. 2016;46 (13-14):843-856 - 14.
Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. The American Journal of Pathology. 2007; 171 (3):715-727 - 15.
Irigoín F, Laich A, Ferreira AM, Fernández C, Sim RB, Díaz A. Resistance of the Echinococcus granulosus cyst wall to complement activation: Analysis of the role of InsP6 deposits. Parasite Immunology. 2008;30 (6-7):354-364 - 16.
Wu J, Wu YQ , Ricklin D, Janssen BJ, Lambris JD, Gros P. Structure of complement fragment C3b–factor H and implications for host protection by complement regulators. Nature Immunology. 2009; 10 (7):728-733 - 17.
Gustafsson MC, Lannergård J, Nilsson OR, Kristensen BM, Olsen JE, Harris CL, et al. Factor H binds to the hypervariable region of many streptococcus pyogenes M proteins but does not promote phagocytosis resistance or acute virulence. PLoS Pathogens. 2013; 9 (4):e1003323 - 18.
Diaz A, Ferreira A, Sim RB. Complement evasion by Echinococcus granulosus : Sequestration of host factor H in the hydatid cyst wall. The Journal of Immunology. 1997;158 (8):3779-3786 - 19.
Wang H, Li J, Pu H, Hasan B, Ma J, Jones MK, et al. Echinococcus granulosus infection reduces airway inflammation of mice likely through enhancing IL-10 and down-regulation of IL-5 and IL-17A. Parasites and vectors. 2014;7 (1):1-13 - 20.
Kanan JH, Chain BM. Modulation of dendritic cell differentiation and cytokine secretion by the hydatid cyst fluid of Echinococcus granulosus . Immunology. 2006;118 (2):271-278 - 21.
Jiménez M, Stoore C, Hidalgo C, Corrêa F, Hernández M, Benavides J, et al. Lymphocyte populations in the adventitial layer of hydatid cysts in cattle: Relationship with cyst fertility status and Fasciola hepatica co-infection. Veterinary Pathology. 2020; 57 (1):108-114 - 22.
Li Z, Zhang C, Li L, Bi X, Yang S, Zhang N, et al. The local immune response during Echinococcus granulosus growth in a quantitative hepatic experimental model. Scientific Reports. 2019;9 (1):1-11 - 23.
Rigano R, Buttari B, Profumo E, Ortona E, Delunardo F, Margutti P, et al. Echinococcus granulosus antigen B impairs human dendritic cell differentiation and polarizes immature dendritic cell maturation towards a Th2 cell response. Infection and Immunity. 2007;75 (4):1667-1678 - 24.
Sun J, Walsh M, Villarino AV, Cervi L, Hunter CA, Choi Y, et al. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. The Journal of Immunology. 2005; 174 (2):742-751 - 25.
Chulanetra M, Chaicumpa W. Revisiting the mechanisms of immune evasion employed by human parasites. Frontiers in Cellular and Infection Microbiology. 2021; 11 :639 - 26.
Nunnari G, Pinzone MR, Gruttadauria S, Celesia BM, Madeddu G, Malaguarnera G, et al. Hepatic echinococcosis: Clinical and therapeutic aspects. World Journal of Gastroenterology: WJG. 2012; 18 (13):1448 - 27.
Kizaki T, Ishige M, Bingyan W, Day NK, Good RA, Onoe K. Generation of CD8+ suppressor T cells by protoscoleces of Echinococcus multilocularis in vitro. Immunology. 1993;79 (3):412 - 28.
Hou X, Shi Y, Kang X, Rousu Z, Li D, Wang M, et al. Echinococcus granulosus : The establishment of the metacestode in the liver is associated with control of the CD4+ T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model. Frontiers in Cellular and Infection Microbiology. 2022;12 :983119 - 29.
Amri M, Mezioug D, Touil-Boukoffa C. Involvement of IL-10 and IL-4 in evasion strategies of Echinococcus granulosus to host immune response. European Cytokine Network. 2009;20 (2):63-68 - 30.
Silva-Álvarez V, Folle AM, Ramos AL, Kitano ES, Iwai LK, Corraliza I, et al. Echinococcus granulosus antigen B binds to monocytes and macrophages modulating cell response to inflammation. Parasites & Vectors. 2016;9 (1):1-17 - 31.
Sefiddashti RR, Sharafi SM, Ebrahimi SA, Akhlaghi L, Moosavi A, Eskandarian A, et al. Antibody response to glycan antigens of hydatid cyst fluid, laminated layer and protoscolex of Echinococcus granulosus . Medical Journal of the Islamic Republic of Iran. 2017;31 :12 - 32.
Ortona E, Margutti P, Delunardo F, Riganò R, Profumo E, Buttari B, et al. Recombinant antigens of Echinococcus granulosus recognized by IgE and IgG4 of sera from patients with cystic echinococcosis. Parassitologia. 2004;46 (4):435 - 33.
Rigano R, Profumo E, Bruschi F, Carulli G, Azzarà A, Ioppolo S, et al. Modulation of human immune response by Echinococcus granulosus antigen B and its possible role in evading host defenses. Infection and Immunity. 2001;69 (1):288-296 - 34.
Bakhtiar NM, Spotin A, Mahami-Oskouei M, Ahmadpour E, Rostami A. Recent advances on innate immune pathways related to host–parasite cross-talk in cystic and alveolar echinococcosis. Parasites & Vectors. 2020; 13 (1):1-8 - 35.
Shnawa BH, Gorony S, Khalid KM. Efficacy of cyperus rotundus rhizomes-tubers extracts against protoscoleces of Echinococcus granulosus. World Journal of Pharmacy Research. 2017; 6 :157-179 - 36.
Paredes R, Jimenez V, Cabrera G, Iragüen D, Galanti N. Apoptosis as a possible mechanism of infertility in Echinococcus granulosus hydatid cysts. Journal of Cellular Biochemistry. 2007;100 (5):1200-1209 - 37.
Amirmajdi MM, Sankian M, Mashhadi IE, Varasteh A, Vahedi F, Sadrizadeh A, et al. Apoptosis of human lymphocytes after exposure to hydatid fluid. Iranian Journal of Parasitology. 2011; 6 (2):9 - 38.
Zhan J, Song H, Wang N, Guo C, Shen N, Hua R, et al. Molecular and functional characterization of inhibitor of apoptosis proteins (IAP, BIRP) in Echinococcus granulosus. Frontiers in Microbiology. 2020; 11 :729 - 39.
Golzari SE, Sokouti M. Pericyst: The outermost layer of hydatid cyst. World Journal of Gastroenterology. 2014; 20 (5):1377-1378 - 40.
Cao S, Gong W, Zhang X, Xu M, Wang Y, Xu Y, et al. Arginase promotes immune evasion of Echinococcus granulosus in mice. Parasites & Vectors. 2020;13 (1):1-12 - 41.
Kotwal GJ. Antigenic Variation in Microbial Evasion of Immune Responses. USA: Wiley; 2001 - 42.
Nieto A, Fernández C, Ferreira Chiesa AM, Díaz Berenguer AR, Baz A, Bentancor A, et al. Mechanisms of evasion of host immune response by E. granulosus. In: Biology of Parasitism: Molecular Biology and Immunology of the Adaptation and Development of Parasites. Montevideo, Uruguay. 1994. pp. 85-98 - 43.
Hilligan KL, Ronchese F. Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses. Cellular & Molecular Immunology. 2020; 17 (6):587-599 - 44.
Pan W, Zhou HJ, Shen YJ, Wang Y, Xu YX, Hu Y, et al. Surveillance on the status of immune cells after Echinnococcus granulosus protoscoleces infection in Balb/c mice. PLoS One. 2013; 8 (3):e59746 - 45.
Wang Y, Zhou H, Shen Y, Wang Y, Wu W, Liu H, et al. Impairment of dendritic cell function and induction of CD4+ CD25+ Foxp3+ T cells by excretory-secretory products: A potential mechanism of immune evasion adopted by Echinococcus granulosus. BMC Immunology. 2015; 16 (1):1-10 - 46.
Lightowlers MW, Lawrence SB, Gauci CG, Young J, Ralston MJ, Maas D, et al. Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunology. 1996; 18 (9):457-462 - 47.
Lightowlers MW, Heath DD. Immunity and vaccine control of Echinococcus granulosus infection in animal intermediate hosts. Parassitologia. 2004;46 (1-2):27-31 - 48.
Haag KL, Gottstein B, Ayala FJ. The EG95 antigen of Echinococcus spp. contains positively selected amino acids, which may influence host specificity and vaccine efficacy. PLoS One. 2009;4 (4):e5362 - 49.
Zhu M, Wang X, Wang H, Wang Z, Zhao J, Wang Y, et al. Mechanism of protective immunity by vaccination with recombinant Echinococcus granulosus glutathione S-transferase (Chinese strain) in mice. Experimental and Therapeutic Medicine. 2015;10 (3):1127-1132 - 50.
Azizi H, Kazemi B, Bandehpour M, Mohebali M, Khamesipour A, Aryaeipour M, et al. Modulation of the immune response to DNA vaccine encoding gene of 8-kda subunit of Echinococcus granulosus antigen B using murine interleukin-12 plasmid in BALB/c mice. Iranian Journal of Parasitology. 2016; 11 (4):480 - 51.
Valizadeh M, Haghpanah B, Badirzadeh A, Roointan E, Fallahi S, Raeghi S. Immunization of sheep against Echinococcus granulosus with protoscolex tegumental surface antigens. Veterinary World. 2017;10 (8):854 - 52.
Zhang W, Zhang Z, Shi B, Li J, You H, Tulson G, et al. Vaccination of dogs against Echinococcus granulosus the cause of cystic hydatid disease in humans. The Journal of Infectious Diseases. 2006;194 (7):966-974 - 53.
Yu M, Zhu Y, Li Y, Chen Z, Sha T, Li Z, et al. Design of a novel multi-epitope vaccine against Echinococcus granulosus in Immunoinformatics. Frontiers in Immunology. 2021;12 :668492